DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network JL Katzman, U Shaham, A Cloninger, J Bates, T Jiang, Y Kluger BMC medical research methodology 18, 1-12, 2018 | 1527 | 2018 |
Association between genomic metrics and immune infiltration in triple-negative breast cancer T Karn, T Jiang, C Hatzis, N Sänger, A El-Balat, A Rody, U Holtrich, ... JAMA oncology 3 (12), 1707-1711, 2017 | 242* | 2017 |
Regulation of glutamine carrier proteins by RNF5 determines breast cancer response to ER stress-inducing chemotherapies YJ Jeon, S Khelifa, B Ratnikov, DA Scott, Y Feng, F Parisi, C Ruller, E Lau, ... Cancer cell 27 (3), 354-369, 2015 | 222 | 2015 |
Immune gene expression is associated with genomic aberrations in breast cancer A Safonov, T Jiang, G Bianchini, B Győrffy, T Karn, C Hatzis, L Pusztai Cancer research 77 (12), 3317-3324, 2017 | 135 | 2017 |
Reliability of whole-exome sequencing for assessing intratumor genetic heterogeneity W Shi, CKY Ng, RS Lim, T Jiang, S Kumar, X Li, VB Wali, S Piscuoglio, ... Cell reports 25 (6), 1446-1457, 2018 | 96 | 2018 |
Predictors of chemosensitivity in triple negative breast cancer: an integrated genomic analysis T Jiang, W Shi, VB Wali, LS Pongor, C Li, R Lau, B Győrffy, RP Lifton, ... PLoS medicine 13 (12), e1002193, 2016 | 95 | 2016 |
Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial W Shi, T Jiang, P Nuciforo, C Hatzis, E Holmes, N Harbeck, C Sotiriou, ... Annals of oncology 28 (1), 128-135, 2017 | 69 | 2017 |
Identification of multi-loci hubs from 4C-seq demonstrates the functional importance of simultaneous interactions T Jiang, R Raviram, V Snetkova, PP Rocha, C Proudhon, S Badri, ... Nucleic acids research 44 (18), 8714-8725, 2016 | 52 | 2016 |
Active and inactive enhancers cooperate to exert localized and long-range control of gene regulation C Proudhon, V Snetkova, R Raviram, C Lobry, S Badri, T Jiang, B Hao, ... Cell reports 15 (10), 2159-2169, 2016 | 51 | 2016 |
Unsupervised ensemble learning with dependent classifiers A Jaffe, E Fetaya, B Nadler, T Jiang, Y Kluger Artificial Intelligence and Statistics, 351-360, 2016 | 49 | 2016 |
Statistical measures of transcriptional diversity capture genomic heterogeneity of cancer T Jiang, W Shi, R Natowicz, SN Ononye, VB Wali, Y Kluger, L Pusztai, ... BMC genomics 15, 1-11, 2014 | 35 | 2014 |
Intratumor heterogeneity of homologous recombination deficiency in primary breast cancer MK von Wahlde, KM Timms, A Chagpar, VB Wali, T Jiang, V Bossuyt, ... Clinical Cancer Research 23 (5), 1193-1199, 2017 | 34 | 2017 |
A Molecular Chipper technology for CRISPR sgRNA library generation and functional mapping of noncoding regions J Cheng, CA Roden, W Pan, S Zhu, A Baccei, X Pan, T Jiang, Y Kluger, ... Nature communications 7 (1), 11178, 2016 | 25 | 2016 |
Global gene expression changes induced by prolonged cold ischemic stress and preservation method of breast cancer tissue B Aktas, H Sun, H Yao, W Shi, R Hubbard, Y Zhang, T Jiang, SN Ononye, ... Molecular oncology 8 (3), 717-727, 2014 | 24 | 2014 |
Non-malignant respiratory epithelial cells preferentially proliferate from resected non-small cell lung cancer specimens cultured under conditionally reprogrammed conditions B Gao, C Huang, K Kernstine, V Pelekanou, Y Kluger, T Jiang, ... Oncotarget 8 (7), 11114, 2017 | 23 | 2017 |
Combined analysis of gene expression, DNA copy number, and mutation profiling data to display biological process anomalies in individual breast cancers W Shi, B Balazs, B Györffy, T Jiang, WF Symmans, C Hatzis, L Pusztai Breast cancer research and treatment 144, 561-568, 2014 | 6 | 2014 |
Metabolic isoenzyme shifts in cancer as potential novel therapeutic targets SN Ononye, W Shi, VB Wali, B Aktas, T Jiang, C Hatzis, L Pusztai Breast cancer research and treatment 148, 477-488, 2014 | 5 | 2014 |
Abstract S1-07: Immune sculpting of the triple negative breast cancer genome T Karn, T Jiang, C Hatzis, N Sänger, A El-Balat, U Holtrich, S Becker, ... Cancer Research 77 (4_Supplement), S1-07-S1-07, 2017 | 4 | 2017 |
Characterization of DNA variants in the human kinome in breast cancer D Agarwal, Y Qi, T Jiang, X Liu, W Shi, VB Wali, B Turk, JS Ross, ... Scientific reports 5 (1), 14736, 2015 | 4 | 2015 |
Abstract P4-04-04: Triple-negative (TN) and HER2+ breast cancers (BC) have different immune milieu in primary and metastatic tumors G Bianchini, M Riba, S Zambelli, A Safonov, R Ogiya, T Jiang, C Hatzis, ... Cancer Research 76 (4_Supplement), P4-04-04-P4-04-04, 2016 | 3 | 2016 |